{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-030269","form_type":"8-K","ticker":"CLNN","cik":"0001822791","company_name":"Clene Inc.","filed_at":"2024-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.683521+00:00","generated_at":"2026-05-31T00:50:39.035058+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Clene amends loan with Avenue; Oct payment cut to $2M, interest-only period tied to equity raise and ALS NDA progress","bullets":["October 2024 principal payment reduced from $3.33M to $2M.","Interest-only period from Nov-Dec 2024 contingent on raising $10M in equity by Oct 31, 2024; $7M raised in Sep 2024.","If FDA allows ALS NDA submission for CNM-Au8 by Dec 31, 2024, loan amortization extends to June 2025; otherwise full repayment by April 2025.","Warrant exercise price lowered from $16.00 to $4.6014 per share for Avenue."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-030269","json":"https://secwatch.observer/filing/0001437749-24-030269.json","markdown":"https://secwatch.observer/filing/0001437749-24-030269.md","text":"https://secwatch.observer/filing/0001437749-24-030269.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822791/000143774924030269/0001437749-24-030269-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822791/000143774924030269/clnn20240928c_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T00:50:39.035058+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}